Recommended Vaccines for Patients 50 Years of Age and Older
May 1, 2016
In general, adult Canadians are underimmunized for routine vaccine-preventable diseases. Primary responsibility for adult immunization falls to family doctors and other primary care providers. To streamline current recommendations for average Canadians, the following table is provided as a tool for everyday use.
Gardasil vaccine safety studies show no new risks
December 11, 2015
After reviewing Canadian and international information regarding the safety of the HPV vaccine Gardasil, Health Canada is informing Canadians that the benefits of using this vaccine continue to outweigh the risks. The overall evidence continues to demonstrate that this vaccine can be safely used and that there are no new safety risks associated with its use.
Update by Sanofi Canada on Nationwide Voluntary Recall of Allerject
December 2, 2015
Following the October 28, 2015 voluntary recall by Sanofi-aventis Canada Inc. (Sanofi Canada) of all lots of Allerject® epinephrine auto-injectors of both the 0.15mg/0.15mL and 0.30mg/0.3mL strengths, and given the recent announcement that stock of alternative epinephrine auto-injectors is now sufficient to replace all Allerject® devices in Canada, Sanofi Canada is notifying the public of the following updates:
Sanofi Canada Issues Voluntary Nationwide Recall Of Allerject
October 28, 2015
Sanofi-aventis Canada Inc. (Sanofi Canada) is recalling all Allerject® (epinephrine injection, USP). The voluntary recall involves all Allerject currently on the market and includes both the 0.15 mg/ 0.15 mL and 0.3 mg/0.3 mL strengths for hospitals, retailers and consumers. The products have been found to potentially have inaccurate dosage delivery. If a patient who is experiencing a serious allergic reaction (i.e., anaphylaxis) did not receive the intended dose, there could be significant health consequences, including death because anaphylaxis is a potentially life-threatening condition.
No causative link found between periodontal disease & heart disease
April 27, 2012
American Heart Assocation issues statement: No causative link found between periodontal disease & heart disease. The American Dental Association Council on Scientific Affairs agrees with the AHA’s conclusions in the statement. Via ADA News.
Supplementary information: JCDA article: Separating Fact from Fiction: Use of High-Level Evidence from
Research Syntheses to Identify Diseases and Disorders Associated with Periodontal Disease.
Read the article
April 10, 2012
Health Canada is informing Canadians that it has requested companies to add new risk statements to the packaging and labelling of licensed benzocaine products.
April 3, 2012
Government official's statement announcing review results indicate Canadians can safely use toothpaste, shampoo and soap containing triclosan.
The Harper Government announced new measures
October 12, 2011
The Harper Government today announced new measures that will provide consumers with more information about energy drinks, to help ensure Canadian families make informed choices when it comes to these popular beverages.
Unlicensed HIV Home Test Kit: Accu-HIV 1 & 2 Saliva Test
September 12, 2011
Following information that a Toronto Company, ACCU-METRICS, has been advertising HIV home test kits for sale via their website, Health Canada would like to remind Canadians that there are currently no HIV test kits that have been authorized for home use in Canada.
For more information, click here
Health Canada reminds Canadians of health risks associated with topical benzocaine products
April 19, 2011
Health Canada is reminding Canadians, including parents and caregivers, about health risks associated with the use of topical benzocaine products, including a rare but potentially serious blood condition known as methemoglobinemia (MetHb). Health Canada continues to receive reports of benzocaine-related adverse reactions, including MetHb. We continue to evaluate the safety of benzocaine products in light of these reports and will take appropriate regulatory actions as warranted.
Topical benzocaine products are available over-the-counter in various concentrations and formulations, including sprays, gels, liquids and creams, and are used to relieve pain from a variety of conditions such as sore throats, teething, toothache, canker sores, irritation of the mouth and gums, burns, insect bites, itching, and hemorrhoids. They are also used by healthcare practitioners during surgical, dental and other medical procedures to numb the mouth and throat.
GlaxoSmithKline issues consumer advisory
February 23, 2010
GlaxoSmithKline Consumer Healthcare issued a consumer advisory warning about the potential health risks associated with long-term excessive use of denture adhesives Poli-Grip ‘Advanced Care’, ‘Extra Strength’ and ‘Ultra Fresh’.
Topical Anesthetics with Serious Side Effects
March 6, 2009
Health Canada, in collaboration with AstraZeneca Canada Inc. and Smith & Nephew Inc., is warning Canadians about the potential hazards of topical anesthetics (e.g. EMLA®, AMETOP Gel™ and locally compounded products). Topical anesthetics are generally approved for numbing the skin before procedures like vaccinations and minor skin surgery. Topical anesthetics are also being used, often without direct medical supervision, to numb large areas of skin before cosmetic procedures such as laser removal of body hair. In recent years there have been reports of serious adverse events including fatalities that have been associated with excessive topical application of local anesthetics in both adult and pediatric patients. Other side effects reported with the use of topical anesthetics also include seizures, irregular heartbeat and difficulty breathing.
Beware Counterfeit Toothbrushes
February 17, 2009
Health Canada is advising Canadian consumers and retailers to exercise caution when purchasing toothbrushes. Counterfeit toothbrushes falsely labelled as Colgate Massager, Colgate Navigator, Oral B Classic 40, Oral B Contura and Colgate 360.